(RYI) Ryerson Holding - Ratings and Ratios
Carbon Steel, Stainless Steel, Alloy Steels, Aluminum, Nickel, Red Metals
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.98% |
| Yield on Cost 5y | 7.14% |
| Yield CAGR 5y | 65.80% |
| Payout Consistency | 100.0% |
| Payout Ratio | 118.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 46.1% |
| Value at Risk 5%th | 70.6% |
| Relative Tail Risk | -6.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | 4.67 |
| CAGR/Max DD | -0.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.467 |
| Beta | 0.987 |
| Beta Downside | 0.752 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.17% |
| Mean DD | 34.86% |
| Median DD | 41.67% |
Description: RYI Ryerson Holding October 22, 2025
Ryerson Holding Corp (NYSE:RYI) is a Chicago-based metals processor and distributor that supplies carbon steel, stainless steel, alloy steels, aluminum, nickel, and other red metals in a wide array of forms-including coils, sheets, bars, plates, and tubing-to manufacturers across sectors such as metal fabrication, industrial equipment, transportation, HVAC, food processing, construction, and oil & gas.
In FY 2023 the company generated roughly $2.5 billion in revenue with an adjusted EBITDA margin near 6%, reflecting the cyclical nature of steel pricing and the firm’s reliance on volume-driven contracts. Key economic drivers include U.S. infrastructure spending (the $1.2 trillion bipartisan infrastructure bill) and global steel supply-demand balances, while sector-specific risks stem from construction activity and oil-price volatility that affect downstream demand for steel products.
For a deeper quantitative assessment, you might explore Ryerson’s metrics on ValueRay to see how its valuation compares to peers and historical trends.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-22.8m TTM) > 0 and > 6% of Revenue (6% = 268.4m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -3.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.45% (prev 15.23%; Δ -0.78pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 66.5m > Net Income -22.8m (YES >=105%, WARN >=100%) |
| Net Debt (826.8m) to EBITDA (90.5m) ratio: 9.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (32.2m) change vs 12m ago -1.75% (target <= -2.0% for YES) |
| Gross Margin 17.98% (prev 18.93%; Δ -0.95pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 178.1% (prev 185.7%; Δ -7.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.23 (EBITDA TTM 90.5m / Interest Expense TTM 39.5m) >= 6 (WARN >= 3) |
Altman Z'' 3.07
| (A) 0.26 = (Total Current Assets 1.30b - Total Current Liabilities 656.9m) / Total Assets 2.49b |
| (B) 0.30 = Retained Earnings (Balance) 742.8m / Total Assets 2.49b |
| (C) 0.00 = EBIT TTM 9.00m / Avg Total Assets 2.51b |
| (D) 0.35 = Book Value of Equity 594.4m / Total Liabilities 1.69b |
| Total Rating: 3.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 30.34
| 1. Piotroski 2.0pt |
| 2. FCF Yield 0.75% |
| 3. FCF Margin 0.27% |
| 4. Debt/Equity 1.09 |
| 5. Debt/Ebitda 9.14 |
| 6. ROIC - WACC (= -4.57)% |
| 7. RoE -2.83% |
| 8. Rev. Trend -85.79% |
| 9. EPS Trend -78.40% |
What is the price of RYI shares?
Over the past week, the price has changed by +4.34%, over one month by +28.00%, over three months by +11.69% and over the past year by +20.28%.
Is RYI a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RYI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24 | -4.8% |
| Analysts Target Price | 24 | -4.8% |
| ValueRay Target Price | 26.7 | 5.7% |
RYI Fundamental Data Overview December 16, 2025
P/S = 0.1815
P/B = 1.0314
P/EG = 0.35
Beta = 1.656
Revenue TTM = 4.47b USD
EBIT TTM = 9.00m USD
EBITDA TTM = 90.5m USD
Long Term Debt = 498.2m USD (from longTermDebt, last quarter)
Short Term Debt = 34.7m USD (from shortTermDebt, last quarter)
Debt = 856.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 826.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.64b USD (812.0m + Debt 856.6m - CCE 29.8m)
Interest Coverage Ratio = 0.23 (Ebit TTM 9.00m / Interest Expense TTM 39.5m)
FCF Yield = 0.75% (FCF TTM 12.3m / Enterprise Value 1.64b)
FCF Margin = 0.27% (FCF TTM 12.3m / Revenue TTM 4.47b)
Net Margin = -0.51% (Net Income TTM -22.8m / Revenue TTM 4.47b)
Gross Margin = 17.98% ((Revenue TTM 4.47b - Cost of Revenue TTM 3.67b) / Revenue TTM)
Gross Margin QoQ = 17.18% (prev 17.91%)
Tobins Q-Ratio = 0.66 (Enterprise Value 1.64b / Total Assets 2.49b)
Interest Expense / Debt = 1.18% (Interest Expense 10.1m / Debt 856.6m)
Taxrate = -39.81% (negative due to tax credits) (4.10m / -10.3m)
NOPAT = 12.6m (EBIT 9.00m * (1 - -39.81%)) [negative tax rate / tax credits]
Current Ratio = 1.98 (Total Current Assets 1.30b / Total Current Liabilities 656.9m)
Debt / Equity = 1.09 (Debt 856.6m / totalStockholderEquity, last quarter 787.3m)
Debt / EBITDA = 9.14 (Net Debt 826.8m / EBITDA 90.5m)
Debt / FCF = 67.22 (Net Debt 826.8m / FCF TTM 12.3m)
Total Stockholder Equity = 804.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.92% (Net Income -22.8m / Total Assets 2.49b)
RoE = -2.83% (Net Income TTM -22.8m / Total Stockholder Equity 804.5m)
RoCE = 0.69% (EBIT 9.00m / Capital Employed (Equity 804.5m + L.T.Debt 498.2m))
RoIC = 0.97% (NOPAT 12.6m / Invested Capital 1.30b)
WACC = 5.54% (E(812.0m)/V(1.67b) * Re(9.65%) + D(856.6m)/V(1.67b) * Rd(1.18%) * (1-Tc(-0.40)))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.71%
[DCF Debug] Terminal Value 63.55% ; FCFE base≈47.9m ; Y1≈31.4m ; Y5≈14.4m
Fair Price DCF = 6.87 (DCF Value 221.1m / Shares Outstanding 32.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -78.40 | EPS CAGR: -49.67% | SUE: -1.25 | # QB: 0
Revenue Correlation: -85.79 | Revenue CAGR: -7.15% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.49 | Chg30d=+0.030 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.34 | Chg30d=-0.105 | Revisions Net=+1 | Growth EPS=+279.3% | Growth Revenue=+7.1%
Additional Sources for RYI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle